http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
-
Comstock announces reverse split of common stock
-
AHF Stands Against Hate in Kingdom Day Parade
-
Comstock Announces Reverse Stock Split
-
Chemours Announces First Quarter Dividend
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
-
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MODV
-
ESGold Closes C$1.1 Million in Strategic Funding Through Warrant Exercises and Concurrent Flow-Through Private Placement
-
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Micron Technology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MU
-
Greenberg Traurig's Michael J. Attisha, Ph.D. Presents at FusionXInvest:Global
-
UroGen Pharma (URGN) Announces Results from Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
-
UroGen Announces Results from Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Red Cat Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RCAT
-
Newline Introduces the DV One+: A Powerful Upgrade to the Ultimate All-in-One LED Display
-
New Book Encourages Teachers to Keep Joy at the Heart of Their Work and Lives
-
THE CORDISH COMPANIES PROUDLY CELEBRATES THE GRAND OPENING OF $270+ MILLION LIVE! CASINO & HOTEL LOUISIANA
-
The Swing Bays Tees Off National Expansion with Multi-Unit Franchise in North Carolina
-
ROSEN, A LEADING LAW FIRM, Encourages Polestar Automotive Holding UK PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - PSNY
-
Banks sell down more X debt; just $1.3 billion now left on their books
-
Broad Arrow Adds Supercar Lineup from the Hobby's Top Marques to The Amelia Auction
-
Broad Arrow Adds Supercar Lineup from the Hobby's Top Marques to The Amelia Auction
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Paladin Energy Ltd Investors to Inquire About Securities Class Action Investigation - PALAF
-
The Podcast Academy Announces Nominees for Fifth Annual Awards for Excellence in Audio
-
HALVIN is launching tomorrow, and the Presale ends Today. Team Unveils the Future of AI-Powered Crypto: Transparent Governance, Innovative Tokenomics, and a Commitment to Social Good
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Electronic Arts Inc. Investors to Inquire About Securities Class Action Investigation - EA
-
Nationally-Recognized Higher Education Leaders Join University Board to Expand Access for Nontraditional, Working, and Military Learners
-
Capstone Green Energy Files Third Quarter Fiscal 2025 Financial Results
-
B. Riley Securities to Host 25th Annual Investor Conference on May 21-22, 2025 in Marina Del Rey, CA
-
SS&C Announces Common Stock Dividend of $0.25 Per Share
-
AbbVie (ABBV) appoints CEO as Chairman of board
-
AITX Subsidiary RAD-R Set to Launch RADCam Version 15, Featuring Enhanced AI-Driven Package Protection and Smarter Home Security
-
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
-
European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
-
Foresight Signs Development Service Agreement with Leading Japanese Manufacturer of Road Traffic and Hazard Management Products
-
Proleo.io Wins Excellence Award At Finext Awards and Conference 2025
-
1847 Holdings Reports CMD Inc. Strong Revenue Growth and Profitability for Fiscal Year 2023 and Nine Months Ended September 30, 2024
-
European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
-
Dominion Lending Centres Inc. Announces Quarterly Dividend
-
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
-
CryptoGO: Simplifying Memecoin Trading for Newcomers on Telegram
-
Calamos Announces Upside Cap Ranges for Upcoming Structured Protection ETFs Providing Exposure to S&P 500 and Nasdaq-100 with 100% Downside Protection Over One Year
-
Taskrabbit Scales Partnership with IKEA Across North America and Europe
-
Roger Rodby, MD, Named NKF's Donald W. Seldin Award Winner
-
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
-
Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
-
Fannie Mae Reports Net Income of $17.0 Billion for 2024 and $4.1 Billion for Fourth Quarter 2024
-
Purepoint Refines High-Priority Targets and Prepares for Drilling at Smart Lake JV Project
